US 12,377,135 B2Granted

GHRH antagonists for use in a method of treating sarcoidosis

AssigneesUniversity of Miami, The United States Government as represented by the Department of Veterans Affairs

InventorsMehdi Mirsaeidi, Chongxu Zhang, Andrew V. Schally, Renzhi Cai

Life of this patent

Estimating the term…

The disclosure provides a method of treating sarcoidosis, the method comprising administering a GHRH antagonist to mammalian subject in need thereof.

Dependent claims

A method of treating sarcoidosis, the method comprising administering a GHRH antagonist to mammalian subject in need thereof.

Dependencies are inferred from the claim text.

A61K 38/16
Medicinal preparations containing peptides: peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
A61K 38/25
Hormones: growth hormone-releasing factor [GH-RF], i.e. somatoliberin
A61P 11/00
Drugs for disorders of the respiratory system
A61P 29/00
Non-central analgesic, antipyretic or antiinflammatory agents

From the US filing history. Foreign family members aren’t listed.

Loading patent…